The Union Health Ministry is launching a nationwide Human Papillomavirus (HPV) vaccination programme targeting 14-year-old girls. This initiative is crucial as it aims to reduce the high incidence of cervical cancer in India, which poses a significant public health concern. The programme is timely, aligning with global health trends towards preventive healthcare and vaccination against HPV.
This topic is relevant for the UPSC exams as it connects with health policy and public health issues. It falls under the Prelims syllabus for current affairs and the Mains syllabus, specifically in GS II (Governance, Constitution, Polity, Social Justice and International relations) and GS III (Health). Understanding this initiative helps aspirants grasp the importance of public health measures in combating diseases.
The HPV vaccination programme will use the Gardasil vaccine, which protects against HPV types 16 and 18, the primary culprits behind cervical cancer. By targeting girls at age 14, the initiative seeks to administer the vaccine before potential exposure to the virus, maximizing its preventive benefits. The programme will be executed through government health facilities, ensuring equitable access across different socio-economic groups.
In the Prelims, questions may focus on the facts surrounding the HPV vaccine, such as the types of HPV it protects against or statistics on cervical cancer in India. Mains questions could delve into the implications of the vaccination programme for public health policy, analyzing its potential impact on women's health and long-term health outcomes in India.
The introduction of the HPV vaccination programme is expected to significantly reduce the incidence of cervical cancer. This initiative not only addresses immediate health concerns but also contributes to broader public health goals, such as improving women's health, enhancing healthcare access in rural areas, and reducing mortality rates associated with cervical cancer. By focusing on preventive measures, the government aims to foster a healthier population and lower future healthcare costs.
The HPV vaccination programme represents a significant step towards enhancing public health in India. By implementing evidence-based policies that prioritize early prevention through vaccination, the initiative seeks to decrease the burden of cervical cancer among women. It highlights the importance of sustainability and resilience in public health strategies, ensuring that all socio-economic groups have access to preventive healthcare measures.
Q1. What is the purpose of the HPV vaccination programme in India?
Answer: The programme aims to reduce cervical cancer rates by vaccinating 14-year-old girls against HPV, which is responsible for the majority of such cases in India.
Q2. How is the HPV vaccine administered in India?
Answer: The Gardasil vaccine will be provided free of cost at government health facilities, ensuring accessibility for all socio-economic groups.
Q3. What types of HPV does the Gardasil vaccine protect against?
Answer: Gardasil protects against HPV types 16, 18, 6, and 11, with types 16 and 18 being primarily linked to cervical cancer.
Q4. Why is vaccination at age 14 considered optimal?
Answer: Vaccinating girls at 14 years old provides maximum preventive benefits before potential exposure to HPV, thus reducing the risk of cervical cancer.
Q5. What role does Gavi play in the HPV vaccination programme?
Answer: Gavi, the Vaccine Alliance, supports the procurement of the vaccine, ensuring adherence to quality standards and increasing accessibility in eligible countries.
Question 1: What is the primary goal of the HPV vaccination programme launched in India?
A) To treat cervical cancer
B) To prevent cervical cancer
C) To increase HPV infections
D) To vaccinate all women over 30
Correct Answer: B
Question 2: Which vaccine is being used in the HPV vaccination programme in India?
A) Gardasil
B) Covaxin
C) MMR Vaccine
D) DTP Vaccine
Correct Answer: A
Question 3: At what age will girls receive the HPV vaccine under the new programme?
A) 10 years
B) 12 years
C) 14 years
D) 16 years
Correct Answer: C
Question 4: Who supports the procurement of the HPV vaccine in India?
A) UNICEF
B) WHO
C) Gavi
D) Red Cross
Correct Answer: C
Kutos : AI Assistant!
